acetylglucosamine has been researched along with Cardiomyopathy, Dilated in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Hou, N; Li, Z; Liu, L; Song, J; Song, Y; Teng, Y; Wang, J; Wang, T; Xin, C; Xu, J; Yang, X; Yu, Z; Zhang, Y | 1 |
1 other study(ies) available for acetylglucosamine and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
PRMT5 Prevents Dilated Cardiomyopathy via Suppression of Protein O-GlcNAcylation.
Topics: Acetylglucosamine; Animals; Cardiomyopathy, Dilated; Cells, Cultured; Glycosylation; Heart Ventricles; Homeostasis; Humans; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Protein-Arginine N-Methyltransferases | 2021 |